EU firms targeted in calls for new biomarkers and drug development tools
This article was originally published in Clinica
Personalised medicine, biomarkers and systems biology are among the collaborative projects aimed specifically at small and medium-sized companies in the latest call for proposals under the EU's funding programme, FP7.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.